Table: Sawai Pharmaceutical -Q1 group results

SAWAI group

14/08/2017 05:00

Aug 14 (Reuters)-  
             Sawai Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               33.65               32.95                      
                   (+2.1 pct)          (+12.1 pct)                   
  Operating            5.38                5.89                      
                   (-8.7 pct)          (-7.3 pct)                    
  Recurring            6.11                5.91                      
                   (+3.3 pct)          (-5.6 pct)                    
  Net                  4.66                4.36                      
                   (+6.9 pct)          (-14.4 pct)                   
  EPS              126.31 yen          118.19 yen                    
  EPS Diluted      126.23 yen          118.13 yen                    
  Ann Div                              130.00 yen       130.00 yen   
  -Q2 div                               65.00 yen        65.00 yen   
  -Q4 div                               65.00 yen        65.00 yen   
   
  NOTE - Sawai Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T  
  ((Tokyo Headline News Desk +813 6441 1812))